Schedule 13G ownership disclosure

Sunesis Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 867328700

Event date: 2018-02-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-070699
Form type
SC 13G
Filer
Boxer Capital, LLC
CIK
CIK 1465837
Filed
Mar 05, 2018
Reporting period
Feb 21, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub